The US has exempted Indian pharmaceuticals from reciprocal tariffs, highlighting the critical role of generic medicines. | ...

The US reciprocal tariffs on India Inc will have a twofold impact, benefiting some Indian exporters compared to higher ...

Large Indian drug manufacturers experienced relief as President Trump's administration decided against imposing expected ...

U.S. President Trump’s sweeping move to impose reciprocal tariffs on all trading partners, with India facing a 27% duty on its exports, has prompted a mixed reaction from market strategists, who see ...

The new “Language Picker” lets viewers pick from the full list of more than 30 languages when watching Netflix on TV ...

Indian pharmaceutical industry welcomes U.S. tariff exemption, boosting stock prices and reinforcing commitment to affordable, quality medicines.

US President Donald Trump’s 26% reciprocal tariff on India is expected to have the greatest impact on the automotive, IT, and ...

US-India pharmaceutical and medical device industries navigate Trump's tariff plan, with potential impacts on exports and ...

On Thursday, 2813 stocks advanced, 1169 declined and 141 remained unchanged, with an advance decline ratio of 2.40 on the Bombay Stock Exchange (BSE), indicating positive closing of stocks in broader ...

Market ended lower on Thursday in the volatile session amid weakness in global markets following higher-than-expected tariff ...

The Board of TC Netherlands has approved a proposal to repurchase issued share capital worth €16.718 million from Tata ...

The pharmaceutical sector, which includes Indian generics that make up 40% of total drug imports in the U.S., is crucial for keeping healthcare affordable.